ASSOCIATION OF CD22 WITH THE B-CELL ANTIGEN RECEPTOR

被引:145
|
作者
PEAKER, CJG
NEUBERGER, MS
机构
[1] Medical Research Council, Laboratory of Molecular Biology, Cambridge
关键词
CD22; ANTIGEN RECEPTOR; B-CELL ACTIVATION; SURFACE IMMUNOGLOBULIN; SIGNALING;
D O I
10.1002/eji.1830230626
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The antigen receptor on B lymphocytes is composed of membrane immunoglobulin sheathed by an alpha/beta heterodimer. This structure is in several respects analogous to the antigen receptor on T cells except that, in the case of the T cell but not the B cell receptor, several receptor-associated proteins have been described which may modulate the effects of antigen interaction (e.g. CD4, CD8, CD2 and CD5). To screen for specific associations with the B cell antigen receptor that might be of only low stoichiometry, we have exploited the sensitivity of in vitro kinase assays. We show that the B cell antigen receptor associates with CD22. The association is specific and stable, but Western blotting reveals it to be of low stoichiometry (0.2 to 2% of membrane immunoglobulin is CD22 associated). The CD22/antigen receptor association was demonstrated with multiple isotypes (IgM, IgD and IgG) and was evident both in Burkitt lymphoma lines and in tonsil cells.Whilst the significance of the association is unknown, it is notable that CD22 is a B cell-specific adhesion molecule which we find contains within its cytoplasmic domain a sequence bearing high homology to the ''Reth motif' implicated in signal transduction. Indeed, CD22 becomes tyrosine phosphorylated less than one minute after antigen-receptor cross-linking. Thus, it is tempting to speculate that interactions involving CD22 assist in the antigen-mediated triggering of B cell activation.
引用
收藏
页码:1358 / 1363
页数:6
相关论文
共 50 条
  • [41] STALing B cell responses with CD22
    Chappell, Craig P.
    Clark, Edward A.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (07): : 2778 - 2780
  • [42] Analysis of murine CD22 during B cell development: CD22 is expressed on B cell progenitors prior to IgM
    Stoddart, A
    Ray, RJ
    Paige, CJ
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (10) : 1571 - 1579
  • [43] AMPLIFICATION OF HUMAN B-CELL ACTIVATION BY A MONOCLONAL-ANTIBODY TO THE B-CELL-SPECIFIC ANTIGEN CD22, BP 130/140
    PEZZUTTO, A
    DORKEN, B
    MOLDENHAUER, G
    CLARK, EA
    JOURNAL OF IMMUNOLOGY, 1987, 138 (01): : 98 - 103
  • [44] INTRAVENOUS IMMUNOGLOBULIN PROMOTES APOPTOSIS OF MATURE HUMAN B LYMPHOCYTES BY USING CD22 TO MODULATE THEIR ANTIGEN B CELL RECEPTOR
    Hillion, S.
    Seite, J-F
    Pers, J-O
    Youinou, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 : A48 - A48
  • [45] Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22
    Oezgoer, Lamia
    Brandl, Carolin
    Shock, Anthony
    Nitschke, Lars
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 (09) : 2260 - 2272
  • [46] EPRATUZUMAB, AN ANTIBODY TARGETING CD22 ON B CELLS, INDUCES PHOSPHOPROTEIN CHANGES FOLLOWING B-CELL RECEPTOR ACTIVATION IN VITRO
    Lumb, S.
    Torbett, N.
    Vendrell, I.
    Turner, H.
    Page, M.
    Hales, P.
    Maloney, A.
    Vanhaesebroeck, B.
    Cutillas, P.
    Shock, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 179 - 179
  • [47] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Aiyun Jin
    Jingjing Feng
    Guoqing Wei
    Wenjun Wu
    Luxin Yang
    Huijun Xu
    Yanlei Zhang
    Jiazhen Cui
    Alex Hongsheng Chang
    Yongxian Hu
    He Huang
    Bone Marrow Transplantation, 2020, 55 : 717 - 721
  • [48] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Jin, Aiyun
    Feng, Jingjing
    Wei, Guoqing
    Wu, Wenjun
    Yang, Luxin
    Xu, Huijun
    Zhang, Yanlei
    Cui, Jiazhen
    Chang, Alex Hongsheng
    Hu, Yongxian
    Huang, He
    BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 717 - 721
  • [49] the role of CD22 and other inhibitory co-receptors in B-cell activation
    Nitschke, L
    CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (03) : 290 - 297
  • [50] CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling
    Tedder, TF
    Tuscano, J
    Sato, S
    Kehrl, JH
    ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 481 - 504